| Is early anticoagulation necessary after biological aortic valve replacement? | |
| | |
MedLine Citation:
|
PMID: 18068239 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Early antithrombotic therapy after biological aortic valve replacement (AVR) is controversial. The aim of this study was to determine the rate of thromboembolic events (TE) without anticoagulation treatment during the first 3 months after surgery. Out of 143 consecutive patients who underwent biological AVR from January 1998 to December 2004, 127 patients who did not receive anticoagulation were included (89%). Events during the first 3 months after surgery included: 2 strokes (1.5%), 2 major bleedings (1.5%) and 9 deaths (7%) (none of them due to TE). In conclusion, the management of patients without antithrombotic treatment after biological AVR seems to be safe due to a low rate of TE. |
| | |
Authors:
|
Mariano Noel Benzadón; Jorge Mario Thierer; Marcelo Trivi; Mariano Vrancic; Sebastian Fieg; Fernando Piccinini; Guillermo Vaccarino; Daniel Navia |
Related Documents
:
|
2794919 - Retrospective analysis of 97 patients with infective endocarditis seen over the past 8 ... 2709859 - The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy. experienc... 16432119 - Long-term results of triple-valve procedure. 2443029 - Total and near-total gastrectomy for gastric cancer in patients over 70 years of age. 1810549 - Bioprosthetic valve durability in the elderly: the second decade. 19110809 - Early echocardiographic evaluation following percutaneous implantation with the self-ex... 10826419 - Severe steroid-unresponsive ulcerative colitis: outcomes of restorative proctocolectomy... 22028389 - Tumor pseudoprogression following radiosurgery for vestibular schwannoma. 8535889 - Combined arthroscopic management of impingement syndrome and acromioclavicular joint ar... |
Publication Detail:
|
Type: Comparative Study; Letter Date: 2007-12-18 |
Journal Detail:
|
Title: International journal of cardiology Volume: 128 ISSN: 1874-1754 ISO Abbreviation: Int. J. Cardiol. Publication Date: 2008 Aug |
Date Detail:
|
Created Date: 2008-08-04 Completed Date: 2009-02-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8200291 Medline TA: Int J Cardiol Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 422-3 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aged, 80 and over Anticoagulants / therapeutic use* Aortic Valve / drug effects, pathology, surgery* Female Follow-Up Studies Heart Valve Prosthesis / adverse effects Heart Valve Prosthesis Implantation / adverse effects* Humans Male Middle Aged Postoperative Complications / epidemiology, prevention & control Retrospective Studies Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: HIV and Long QT syndrome--cause or coincidence.
Next Document: Standard measures of right ventricular function assessment in adult patients with acute sickle cell ...